[Form 4] Invivyd, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Paul Bolno, a director of Invivyd, Inc. (IVVD), was granted a stock option on 09/22/2025 to buy 100,000 shares of common stock at an exercise price of $1.22 per share. The option expires on 09/21/2035. The grant vests over three years: one-third vests on the first anniversary of the grant and the remainder vests in equal monthly installments (1/36th) thereafter, subject to continuous service through each vesting date. Following the grant, the reporting person beneficially owns 100,000 option shares, held directly. The Form 4 was filed with a signature dated 09/24/2025 by an attorney-in-fact.

Positive

• Equity alignment: Grant ties the director's interests to long-term shareholder value through time-based vesting.
• Clear vesting schedule: One-third at one year then monthly vesting provides predictable retention incentives.

Negative

• Potential dilution: The exercise of 100,000 options will increase share count if exercised.
• No performance vesting: Vesting is solely time-based, not tied to company performance milestones.

Insights

Corporate Governance Expert

TL;DR: A routine director option grant with time-based vesting, standard for board alignment and retention.

The grant of 100,000 options at $1.22 with a ten-year term and a three-year vesting schedule is consistent with common board compensation practices intended to align the director's interests with long-term shareholder value. The direct ownership of the options simplifies disclosure and avoids layered indirect ownership complexities. There is no indication in the filing of performance-based vesting or acceleration provisions. From a governance perspective, this is a routine, time-based equity award disclosed under Section 16.

Compensation Analyst

TL;DR: Typical retention-focused equity grant; impact depends on company size and total dilution from outstanding equity.

The terms—exercise price $1.22, expiration 09/21/2035, and time-based vesting—signal a standard retention and incentive award for a director. Without data on total shares outstanding or aggregate option pool use, the materiality of 100,000 options cannot be assessed from this filing alone. The absence of performance conditions suggests compensation is tied to service tenure rather than specific milestones.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BOLNO PAUL

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.22	09/22/2025		A		100,000		(1)	09/21/2035	Common Stock	100,000	$0.00	100,000	D

Explanation of Responses:

1. This option was granted on September 22, 2025 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.

	/s/ Jill Andersen attorney-in-fact for Paul Bolno	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paul Bolno report on Form 4 for IVVD?

He reported a grant of 100,000 stock options on 09/22/2025 with an exercise price of $1.22 and expiration 09/21/2035.

What is the vesting schedule for the option grant?

Vesting over three years: one-third vests on the first anniversary and the remainder vests in equal monthly installments (1/36th) thereafter.

How many option shares does the reporting person beneficially own after the transaction?

100,000 option shares beneficially owned directly following the reported transaction.

When was the Form 4 filed and signed?

Form signed by attorney-in-fact on 09/24/2025 and reports the transaction dated 09/22/2025.

What is the exercise price and expiration date of the option?

Exercise price $1.22; expiration date 09/21/2035.